Modular Medical Inc Dossier
Qualitative Analysis
Business overview
Modular Medical, Inc. (NASDAQ: MODD) is a development-stage medical device company focused on designing, developing, and commercializing innovative, easy-to-use, and affordable insulin pumps. The company's primary mission is to expand the insulin pump market to a broader audience of "almost-pumpers"—individuals with Type 1 and Type 2 diabetes who currently rely on multiple daily injections (MDI) but avoid traditional pumps due to their complexity, bulkiness, and high cost. Modular Medical's product portfolio features the MODD1, which received FDA 510(k) clearance in September 2024, and its successor, the Pivot, a tubeless patch pump designed to simplify diabetes management down to minimal settings and a short training session.
Research as of 20 Jun 2026
Strategic Initiatives
Growth programs, investments, and their expected impact
Launching the Pivot tubeless insulin patch pump to target the underserved $3 billion 'almost-pumper' market, consisting of insulin-dependent adults currently relying on multiple daily injections (MDI) due to the complexity and cost of traditional pumps.
Expected impact: Establishes a commercial footprint in the U.S. diabetes care market and drives initial top-line growth.
Advancing through the regulatory pathway to secure CE Mark certification under the European Union Medical Device Regulation (EU MDR 2017/745) to market the Pivot system in Europe.
Expected impact: Allows entry into European markets where high cost and complexity have historically limited pump adoption.
Partnering with tier-one medical contract manufacturer Phillips-Medisize to transition pilot line manufacturing operations to high-volume production facilities.
Expected impact: Enables rapid, low-cost production scaling while maintaining strict FDA-compliant quality systems.
Mergers, Acquisitions & Partnerships
Recent deals and strategic collaborations
Strategic Partnerships
Provides Modular Medical with design, development, and high-volume manufacturing capabilities, leveraging Phillips-Medisize's global supply chain and medical device expertise to scale production of the Pivot pump.
Terms: Terms include fee-for-service manufacturing and assembly operations across facilities in Mexico.
Collaborating to develop an adaptive, full closed-loop Automated Insulin Delivery (AID) system that does not require mealtime announcements, integrating Nudge BG's technology into Modular Medical's pipeline.
Terms: Licensing and collaboration terms to co-develop the next-generation AID system.